Evaluation of genetic predisposition to insulin resistance by nutrient-induced insulin output ratio (NIOR)

Clinical Chemistry and Laboratory Medicine

Volumn 45, Issue 9, 2007, Pages 1124-1132

  Wybranska, Iwona ^a   Malczewska Malec, Malgorzata ^a   Partyka, Lukasz ^a   Kiec Wilk, Beata ^a   Kosno, Katarzyna ^a   Leszczynska Golabek, Iwona ^a   Zdzienicka, Anna ^a   Gruca, Anna ^a   Kwasniak, Malgorzata ^a   Dembinska Kiec, Aldona ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Gene polymorphisms; Individualized nutrition; Insulin resistance; Metabolic syndrome; Obesity; Prognostic marker

Indexed keywords

ADIPONECTIN; GENOMIC DNA; LEPTIN;

AREA UNDER THE CURVE; ARTICLE; BODY MASS; CARBOHYDRATE METABOLISM; CONTROLLED STUDY; DIET; DNA POLYMORPHISM; FEMALE; GENETIC PREDISPOSITION; GROUPS BY AGE; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; LIPID DIET; MAJOR CLINICAL STUDY; MALE; NUTRIENT; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PHENOTYPE; PRIORITY JOURNAL; SEX DIFFERENCE; WAIST HIP RATIO;

ADULT; AREA UNDER CURVE; BODY MASS INDEX; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GHRELIN; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; LIPIDS; MALE; MIDDLE AGED; MUTATION; OBESITY; POLYMORPHISM, GENETIC; VARIATION (GENETICS);

EID: 34548635594     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2007.142     Document Type: Article

References (41)

1. Martin LJ, North KE, Dyer T, Blangero J, Comuzzie AG, Williams J. Phenotypic, genetic, and genome-wide structure in the metabolic syndrome. BMC Genet 2003;4(Suppl 1):S95.
2. Desiere F. Towards a systems biology understanding of human health: interplay between genotype, environment and nutrition. Biotechnol Annu Rev 2004;10:51-84.
3. Zeisel SH, Freake HC, Bauman DE, Bier DM, Burrin DG, German JB, et al. The nutritional phenotype in the age of metabolomics. J Nutr 2005;135:1613-6.
4. Go VL, Wong DA, Wang Y, Butrum RR, Norman HA, Wilkerson L. Diet and cancer prevention: evidence-based medicine to genomic medicine [review]. J Nutr 2004;134(Suppl 12):3513S-6.
5. Daniel H. Genomics and proteomics: importance for the future of nutrition research [review]. Br J Nutr 2002;87(Suppl 2):S305-11.
6. German B, Young VR. Nutrition and genomics [review]. Nestle Nutr Workshop Ser Clin Perform Programme 2004;9:243-61; discussion 261-3.
7. Go VL, Wang Y, Yang H, Lee WN. Neuro-hormonal integration of metabolism: challenges and opportunities in the postgenomic era [review]. Nestle Nutr Workshop Ser Clin Perform Programme 2004;9:227-38; discussion 238-42.
8. Muller M, Kersten S. Nutrigenomics: goals and strategies [review]. Nat Rev Genet 2003;4:315-22.
9. Harano Y, Suzuki M, Koyama Y, Kanda M, Yasuda S, Suzuki K, et al. Multifactorial insulin resistance and clinical impact in hypertension and cardiovascular diseases. J Diabetes Complications 2002;16:19-23.
10. Whitfield PD, German AJ, Noble PJ. Metabolomics: an emerging postgenomic tool for nutrition [review]. Br J Nutr 2004;92:549-55.
11. German JB, Bauman DE, Burrin DG, Failla ML, Freake HC, King JC, et al. Metabolomics in the opening decade of the 21st century: building the roads to individualized health. J Nutr 2004;134:2729-32.
12. Couderc R, Peynet J, Cambillaud M, Tallet F, Cosson C, Lefevre G, et al. Effects of postprandial hyperlipemia on the vitamin E content of lipoproteins. Clin Chim Acta 1998;277:141-52.
13. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
14. American College of Physicians. American Society of Internal Medicine. Primer on absolute vs. relative difference. Effective Clin Pract 1999;2:46.
15. Deeb SS, Fajas L, Nemoto M, Pihlajamäki J, Mykkänen L, Kuusisto J. et al. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 1998;20:284-7.
16. Riemens, SC, Van Tol A, Stulp BK, Dullaart RP. Influence of insulin sensitivity and the TaqIB cholesteryl ester transfer protein gene polymorphism on plasma lecithin: cholesterol acyltransferase and lipid transfer protein activities and their response to cholesteryl ester transfer protein (CETP), phospholipid transfer protein (PLTP), and lipoprotein lipases are involved in hyperinsulinemia in non-diabetic men. J Lipid Res 1999;40:1467-74.
17. Jemaa R, Tuzet S, Portos C, Betoulle D, Apfelbaum M, Fumeron F. Lipoprotein lipase gene polymorphisms: associations with hypertriglyceridemia and body mass index in obese people. Int J Obes Relat Metab Disord 1995;19:270-4.
18. Olivieri O, Bassi A, Stranieri C, Trabetti E, Martinelli N, Pizzolo F, et al. Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease. J Lipid Res 2000;44:2374-81.
19. Nagai N, Sakane N, Ueno LM, Hamada T, Moritani T. The -3826 A → G variant of the uncoupling protein-1 gene diminishes postprandial thermogenesis after a high fat meal in healthy boys. J Clin Endocrinol Metab 2003;88:5661-7.
20. Hoffstedt J, Poirier O, Thorne A, Lonqvist F, Herrmann SM, Carnbien F, et al. Polymorphism of the human beta(3)-adrenoceptor gene forms a well-conserved haplotype that is associated with moderate obesity and altered receptor function. Diabetes 1999;48:203-5.
21. Mori Y, Kim-Motoyama H, Ito Y, Katakura T, Yasuda K, Ishiyama-Shigemoto S, et al. The Gln27Glu beta2-adrenergic receptor variant is associated with obesity due to subcutaneous fat accumulation in Japanese men. Biochem Biophys Res Commun 1999;258:138-40.
22. Comings DE, Flanagan SD, Dietz G, Muhleman D, Knell E, Gysin R. The dopamine D2 receptor (DRD2) as a major gene in obesity and height. Biochem Med Metab Biol 1993;50:176-85.
23. Dalziel B, Gosby AK, Richman RM, Bryson JM, Caterson ID. Association of the TNF-alpha -308 G/A promoter polymorphism with insulin resistance in obesity. Obes Res 2002;10:401-7.
24. Chouchane L, Danguir J, Beji C, Bouassida K, Camoin L, Sfar H, et al. Genetic variation in the stress protein hsp70-2 gene is highly associated with obesity. Int J Obes Relat Metab Disord 2001;25:462-6.
25. Yanagisawa K, Hingstrup Larsen L, Andersen G, Drivsholm T, Cederberg A, Westergren R, et al. The FOXC2 -512C → T variant is associated with hypertriglyceridaemia and increased serum C-peptide in Danish Caucasian glucose-tolerant subjects. Diabetologia 2003;46:1576-80.
26. Brouillette C, Bosse Y, Perusse L, Gaudet D, Vohl MC. Effect of liver fatty acid binding protein (FABP) T94A missense mutation on plasma lipoprotein responsiveness to treatment with fenofibrate. J Hum Genet 2004;49:424-32.
27. Schalin-Jantti C, Valli-Jaakola K, Oksanen L, Martelin E, Laitinen K, Krusius T, et al. Melanocortin-3-receptor gene variants in morbid obesity. Int J Obes Relat Metab Disord 2003;27:70-4.
28. Acton S, Osgood D, Donoghue M, Corella D, Pocovi M, Cenarro A, et al. Association of polymorphisms at the SR-BI gene locus with plasma lipid levels and body mass index in a white population. Arterioscler Thromb Vasc Biol 1999;19:1734-43.
29. Ma X, Bacci S, Mlynarski W, Gottardo L, Soccio T, Menzaghi C, et al. A common haplotype at the CD36 locus is associated with high free fatty acid levels and increased cardiovascular risk in Caucasians. Hum Mol Genet 2004;13:2197-205.
30. Elosua R, Demissie S, Cupples LA, Meigs JB, Wilson PW, Schaefer EJ, et al. Obesity modulates the association among APOE genotype, insulin, and glucose in men. Obes Res 2003;11:1502-8.
31. Carpenter KJ. A short history of nutritional science: part 3 (1912-1944). J Nutr 2003;133:3023-32.
32. World Health Organization: WHO Expert Committee on Diabetes Mellitus. Second Report. Geneva, WHO, 1980.
33. Coates PA, Ollerton RL, Luzio SD, Ismail I, Owens DR. A glimpse of the "natural history" of established type 2 (non-insulin dependent) diabetes mellitus from the spectrum of metabolic and hormonal responses to a mixed meal at the time of diagnosis. Diabetes Res Clin Pract 1994;26:177-87.
34. Igarashi M, Hirata A, Yamauchi T, Yamaguchi H, Tsuchiya H, Ohnuma H, et al. Clinical utility and approach to estimate postprandial hypertriglyeridcemia by a newly designed oral fat-loading test. Atheroscler Thromb 2003;10:314-20.
35. Marcoux C, Hopkins PN, Wang T, Leary ET, Nakajima K, Davignon J, et al. Remnant-like particle cholesterol and triglyceride levels of hypertriglyceridemic patients in the fed and fasted state. J Lipid Res 2000;41:1428-36.
36. Harano Y, Miyawaki T, Nabiki J, Shibachi M, Adachi T, Ikeda M, et al. Development of cookie test for the simultaneous determination of glucose intolerance, hyperinsulinemia, insulin resistance and postprandial dyslipidemia. Endocr J 2006;53:173-80.
37. Poitout V, Hagman D, Stein R, Artner I, Robertson RP, Harmon JS. Regulation of the insulin gene by glucose and fatty acids. J Nutr 2006;136:873-6.
38. Perez-Martinez P, Perez-Jimenez F, Bellido C, Ordovas JM, Moreno JA, Marin C, et al. A polymorphism exon 1 variant at the locus of the scavenger receptor class B type I (SCARB1) gene is associated with differences in insulin sensitivity in healthy people during the consumption of an olive oil-rich diet. J Clin Endocrinol Metab 2005;90:2297-300.
39. Olivieri O, Martinelli N, Sandri M, Bassi A, Guarini P, Trabetti E, et al. Apolipoprotein C-III, n-3 polyunsaturated fatty acids, and "insulin-resistant" T-455C APOC3 gene polymorphism in heart disease patients: example of gene-diet interaction. Clin Chem 2005;51:360-7.
40. Salas J, Jansen S, Lopez-Miranda J, Ordovas JM, Castro P, Marin C, et al. The SstI polymorphism of the apolipoprotein C-III gene determines the insulin response to an oral-glucose-tolerance test after consumption of a diet rich in saturated fats. Am J Clin Nutr 1998;68:396-401.
41. Wansink B, Westgren RE, Cheney MM. Hierarchy of nutritional knowledge that relates to the consumption of a functional food. Nutrition 2005;21:264-8.